Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
C

Captor Therapeutics SA
WSE:CTX

Watchlist Manager
Captor Therapeutics SA
WSE:CTX
Watchlist
Price: 71.3 PLN -1.52%
Market Cap: zł452.8m
Write Note Create Alert Ask AI

Wall St Price Targets

CTX Price Targets Summary
Captor Therapeutics SA

Wall Street analysts forecast CTX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTX is 68.34 PLN with a low forecast of 67.67 PLN and a high forecast of 70.35 PLN.

CTX Lowest Forecast
Wall Street Target
zł67.67
-5% Downside
CTX Average Forecast
Wall Street Target
zł68.34
-4% Downside
CTX Highest Forecast
Wall Street Target
zł70.35
-1% Downside
Lowest Forecast
Price Target
67.67 PLN
5% Downside
Average Forecast
Price Target
68.34 PLN
4% Downside
Highest Forecast
Price Target
70.35 PLN
1% Downside
Captor Therapeutics SA Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
204% / Year
Estimated Growth
Estimates Accuracy
-30%
Average Miss
N/A
Past Growth
204% / Year
Estimated Growth
Estimates Accuracy
-30%
Average Miss

The compound annual growth rate for Revenue over the next 3 years is 204%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

What are analyst estimates?

Continue CTX Research

Summary
CTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
CTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CTX stock valuation using valuation multiples.
Wall St Estimates
CTX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Captor Therapeutics SA listings:
F • EUR
60Q
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CTX's stock price target?
Price Target
68.34 PLN

According to Wall Street analysts, the average 1-year price target for CTX is 68.34 PLN with a low forecast of 67.67 PLN and a high forecast of 70.35 PLN.

What is the Revenue forecast for Captor Therapeutics SA?
Projected CAGR
204%

The compound annual growth rate for Revenue over the next 3 years is 204%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.